The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth-Reference-Cited by-同舟云学术

The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth

Published:2016-05-19 Issue:24 Volume:7 Page:37103-37120
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Trousil Sebastian¹,Kaliszczak Maciej¹,Schug Zachary²,Nguyen Quang-De¹,Tomasi Giampaolo¹,Favicchio Rosy¹,Brickute Diana¹,Fortt Robin¹,Twyman Frazer J.¹,Carroll Laurence¹,Kalusa Andrew¹,Navaratnam Naveenan³,Adejumo Thomas³,Carling David³,Gottlieb Eyal²,Aboagye Eric O.¹

Affiliation:

1. Comprehensive Cancer Imaging Centre, Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK

2. Cancer Research UK, Beatson Institute, Garscube Estate, Glasgow, UK

3. Cellular Stress Group, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, Hammersmith Campus, London, UK

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Directing novel ChoKα1 inhibitors using MamC-mediated biomimetic magnetic nanoparticles: a way to improve specificity and efficiency;Bioorganic Chemistry;2024-10

2. Inhibition of glioblastoma cell proliferation and invasion by the choline-kinase inhibitor JAS239 varies with cell type and hypoxia;2024-01-20

3. Choline kinase and miR-32-5p: A crucial interaction promoting apoptosis and delaying wound repair in cervical cancer cells;AIMS Biophysics;2024

4. Inhibition of choline kinase as an antiamoebic approach in Entamoeba histolytica infection;Tropical Biomedicine;2023-12-31

5. Bench to Bedside Development of [18F]Fluoromethyl-(1,2-2H4)choline ([18F]D4-FCH);Molecules;2023-12-08